CAR-T线

Dimitrios Farmakis1, Konstantinos I Karampinos1, Raul Cordoba2

  • 1Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens Medical School, Athens, Greece.

PubMed
概括

化学抗原受体 (CAR) -T细胞治疗可以导致心血管不良事件 (CVAE). 这项研究确定了七种CVAE预测因子,并开发了CART-7评分,用于接受CAR-T细胞治疗的患者的风险分层.